Eynullayeva相关文献与解析，生知库 | 链接生命科学的每一步

Experiences of patient and care partner dyads in early Alzheimer's disease: a mixed-method study in the United States

美国早期阿尔茨海默病患者及其照护伙伴的经历：一项混合方法研究

doi:10.1080/17582024.2025.2542700

Lv, Lei; Fazio-Eynullayeva, Elnara; Mystkowski, Paul; McKay, Caroline; Al-Zubeidi, Tamara; Miller, Jordan; McKee, Stephanie; Bottomley, Catherine; Floegel, Catherine; Hyde, Richard; Aly, Abdalla

阿尔茨海默症

发表日期：2025

文献求助收藏

A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States

美国阿尔茨海默病患者临床历程、诊断和监测模式按阶段的真实世界分析

期刊:

影响因子:

doi:10.1177/15333175251375378

Fazio-Eynullayeva, Elnara; Mystkowski, Paul; Lv, Lei; Aly, Abdalla; Cotton, Sarah; Grant, Nikisha; Johnson, Will; Mattke, Soeren

阿尔茨海默症

发表日期：2025

文献求助收藏

Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke

首次缺血性卒中后合并房颤和颈动脉疾病患者使用抗血小板药物和口服抗凝剂

期刊:Cardiovascular Drugs and Therapy

影响因子:3.1

doi:10.1007/s10557-023-07433-4

Harrison, Stephanie L; Buckley, Benjamin J R; Lane, Deirdre A; Fazio-Eynullayeva, Elnara; Underhill, Paula; Hill, Andrew; Werring, David J; Lip, Gregory Y H

血小板

发表日期：2024

文献求助收藏

Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19

运动康复与合并新冠肺炎的心血管疾病患者死亡率和住院率降低相关。

期刊:European Journal of Preventive Cardiology

影响因子:7.5

doi:10.1093/eurjpc/zwaa135

Buckley, Benjamin J R; Harrison, Stephanie L; Fazio-Eynullayeva, Elnara; Underhill, Paula; Jones, Ian D; Williams, Nefyn; Lip, Gregory Y H

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation

左心耳封堵术与非维生素K拮抗剂口服抗凝剂治疗房颤的疗效比较

期刊:Clinical Research in Cardiology

影响因子:3.7

doi:10.1007/s00392-021-01983-z

Ding, Wern Yew; Rivera-Caravaca, José Miguel; Fazio-Eynullayeva, Elnara; Underhill, Paula; Gupta, Dhiraj; Marín, Francisco; Lip, Gregory Y H

发表日期：2022

文献求助收藏

Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters

新冠疫情对癌症相关诊疗的演变影响

期刊:JCO Clinical Cancer Informatics

影响因子:2.8

doi:10.1200/CCI.21.00200

London, Jack W; Fazio-Eynullayeva, Elnara; Palchuk, Matvey B; McNair, Christopher

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

在合并心血管代谢疾病的 COVID-19 门诊患者中，直接口服抗凝剂与维生素 K 拮抗剂的疗效和安全性比较

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-021-01368-6

Rivera-Caravaca, José Miguel; Harrison, Stephanie L; Buckley, Benjamin J R; Fazio-Eynullayeva, Elnara; Underhill, Paula; Marín, Francisco; Lip, Gregory Y H

代谢

发表日期：2021

文献求助收藏

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

终末期肾病与成人（无论是否感染新冠病毒）30天死亡率

期刊:European Journal of Internal Medicine

影响因子:6.1

doi:10.1016/j.ejim.2020.11.003

Harrison, Stephanie L; Buckley, Benjamin J R; Fazio-Eynullayeva, Elnara; Underhill, Paula; Lane, Deirdre A; Lip, Gregory Y H

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data

心肌病患者房颤：真实世界数据的患病率和临床结局

期刊:Journal of the American Heart Association

影响因子:5.3

doi:10.1161/JAHA.121.021970

Buckley, Benjamin J R; Harrison, Stephanie L; Gupta, Dhiraj; Fazio-Eynullayeva, Elnara; Underhill, Paula; Lip, Gregory Y H

Association of systemic inflammatory biomarkers with the clinical forms of acute cholecystitis

系统性炎症生物标志物与急性胆囊炎临床表现的相关性

Experiences of patient and care partner dyads in early Alzheimer's disease: a mixed-method study in the United States

美国早期阿尔茨海默病患者及其照护伙伴的经历：一项混合方法研究

A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States

美国阿尔茨海默病患者临床历程、诊断和监测模式按阶段的真实世界分析

Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke

首次缺血性卒中后合并房颤和颈动脉疾病患者使用抗血小板药物和口服抗凝剂

Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19

运动康复与合并新冠肺炎的心血管疾病患者死亡率和住院率降低相关。

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation

左心耳封堵术与非维生素K拮抗剂口服抗凝剂治疗房颤的疗效比较

Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters

新冠疫情对癌症相关诊疗的演变影响

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

在合并心血管代谢疾病的 COVID-19 门诊患者中，直接口服抗凝剂与维生素 K 拮抗剂的疗效和安全性比较

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

终末期肾病与成人（无论是否感染新冠病毒）30天死亡率

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data

心肌病患者房颤：真实世界数据的患病率和临床结局